NIH-funded research P01 program project

Understanding vaccine responses in rhesus macaques

Official title: Core C: Systems Biology Core

Funded at University of Washington · NIH-10897314 · Data updated 2026-11-12

This study is looking at how a specific vaccine works in monkeys to help improve vaccines for people, focusing on how a substance called IL-15 can boost the vaccine's effectiveness against a virus similar to HIV.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startAugust 1, 2023
Project endAugust 2, 2024
Funding year2024
Award (this year)$40,572
NIH project number5P01AI177688-02
Project IDNIH-10897314 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research are individuals involved in pre-clinical studies of SIV vaccines, particularly those with a focus on immune response analysis.

Less likely to help

Patients not involved in SIV vaccine research or those without a relevant immune response condition may not receive any benefit from this research.

What this research studies

This research focuses on generating detailed gene expression data to analyze how vaccines respond in rhesus macaques, particularly in relation to the RHCMV/SIV vaccine and the role of IL-15 in enhancing vaccine protection. The Systems Biology Core will utilize advanced techniques such as next-generation sequencing and NanoString nCounter analyses to assess immune responses from various biological samples. By managing and analyzing large datasets, the research aims to provide insights that could inform future vaccine development and improve protective strategies against SIV.

Why it matters

Potential benefit: If successful, this research could lead to improved vaccine strategies that enhance immune responses against SIV, potentially benefiting future vaccine development for humans.

How similar studies have gone: Other research has shown success in using high-throughput sequencing and functional genomics to analyze immune responses, indicating that this approach is promising and has been validated in similar contexts.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Gale, Michael — University of Washington
  • Study coordinator: Gale, Michael

Related research

Other NIH-funded projects on the same topics.

  • Making genetic testing more accessible to the public

    This study is all about making it easier for people at risk of certain cancers, like breast, ovarian, and colon cancers, to get genetic testing, so we can find out what helps them access these important services and understand how they can benefit from them.

    NIH research University of Washington · Seattle, United States · NIH-9845571

  • Breast cancer diagnosis in low-resource settings using millifluidics and fast digital imaging in Ghana

    A new project will test a fast, low-cost way to diagnose breast cancer at the point of care in Ghana using small-batch fluidics and direct digital imaging.

    NIH research University of Washington · Seattle, United States · NIH-11645064

  • Binaural Hearing and Speech in Noise in Children

    This project explores how children hear speech in noisy classrooms using how the two ears work together to see if binaural processing differences explain why some kids struggle more than others.

    NIH research University of Washington · Seattle, United States · NIH-11631484

  • Neural circuits that control pain aversion in the brain

    Researchers are exploring how a specific brain area helps people feel and avoid pain, with potential to lead to better pain treatments.

    NIH research University of Washington · Seattle, United States · NIH-11629742

  • United World Antiviral Research Network (UWARN)

    A collaborative, international effort is testing new virus surveillance and evolution ideas to help people living with HIV and communities in LMICs stay safer from current and emerging viruses.

    NIH research University of Washington · Seattle, United States · NIH-11627864

  • HF endotypes in heart failure using ethical multi-modal AI and molecular data

    A patient-friendly project that uses advanced AI and multiple kinds of health data to identify distinct heart failure subtypes that could guide personalized care.

    NIH research University of Washington · Seattle, United States · NIH-11621806

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.